Results 151 to 160 of about 22,623 (220)

Fatty acid amide hydrolase activity in the dorsal periaqueductal gray attenuates neuropathic pain and associated dysautonomia.

Am J Physiol Regul Integr Comp Physiol, 2022
Woyach V, Sherman K, Hillard CJ, Hopp FA, Hogan QH, Dean C.   +5 more
europepmc   +1 more source

Deletion of fatty acid amide hydrolase reduces lyso-sulfatide levels but exacerbates metachromatic leukodystrophy in mice. [PDF]

J Biol Chem, 2021
Yaghootfam C, Gehrig B, Sylvester M, Gieselmann V, Matzner U.   +4 more
europepmc   +1 more source

4,4-Dimethylsterols Reduces Fat Accumulation via Inhibiting Fatty Acid Amide Hydrolase In Vitro and In Vivo. [PDF]

Research (Wash D C)
Zhang T, Xie L, Guo Y, Wang Z, Guo X, Liu R, Jin Q, Chang M, Wang X.   +8 more
europepmc   +1 more source

The effects of fatty acid amide hydrolase inhibition and monoacylglycerol lipase inhibition on habit formation in mice. [PDF]

Eur J Neurosci, 2022
Gianessi CA, Groman SM, Taylor JR.
europepmc   +1 more source

The efficacy of elevating anandamide via inhibition of fatty acid amide hydrolase (FAAH) combined with internet-delivered cognitive behavioral therapy in the treatment of post-traumatic stress disorder: a randomized, placebo-controlled clinical trial. [PDF]

Neuropsychopharmacology
Mayo LM, Gauffin E, Petrie GN, Tansey R, Mazurka R, Haggarty CJ, Jones MR, Engelbrektsson H, Aminoff V, Hühne-Landgraf A, Schmidt ME, Pemberton DJ, Fredlund C, Östman L, Karlsson H, Löfberg A, Pietrzak M, Andersson G, Capusan AJ, Hill MN, Heilig M.   +20 more
europepmc   +1 more source

Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study. [PDF]

Neuropsychopharmacology
Klein ME, Bangerter A, Halter RJ, Cooper K, Aguilar Z, Canuso CM, Drevets WC, Schmidt ME, Pandina G.   +8 more
europepmc   +1 more source

4-Phenyl-thiazole-based dual inhibitors of fatty acid amide hydrolase and soluble epoxide hydrolase do not alleviate orofacial inflammatory pain in female rats. [PDF]

BBA Adv
Carr D, Chin C, Chacon T, Herawi MK, Gonzalez M, West R, Morisseau C, Hammock BD, Pecic S, Kandasamy R.   +9 more
europepmc   +1 more source

Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers [PDF]

, 2016

core   +1 more source

Evaluating Fatty Acid Amide Hydrolase as a Suitable Target for Sleep Promotion in a Transgenic TauP301S Mouse Model of Neurodegeneration. [PDF]

Pharmaceuticals (Basel)
Martin SC, Joyce KK, Harper KM, Harp SJ, Cohen TJ, Moy SS, Diering GH.   +6 more
europepmc   +1 more source

Effect of MCH1, a fatty-acid amide hydrolase inhibitor, on the depressive-like behavior and gene expression of endocannabinoid and dopaminergic-signaling system in the mouse nucleus accumbens. [PDF]

Braz J Med Biol Res
Medina-Saldivar C, Pardo GVE, Pacheco-Otalora LF.   +2 more
europepmc   +1 more source